Skip to main content

Lexagene Holdings Inc(LXG-X)
TSX Venture

Today's Change
Real-Time Last Update
Volume

Latest News

Closing Bell: Lexagene Holdings Inc up on Thursday (LXG)
The Globe and Mail - Thu Jan 26, 3:03PM CST
The Globe and Mail
Thu Jan 26, 3:03PM CST
Lexagene Holdings: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (LXG)
The Globe and Mail - Mon Dec 26, 2022
The Globe and Mail
Mon Dec 26, 2022
Lexagene Holdings is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation...
Lexagene Holdings: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (LXG)
The Globe and Mail - Mon Nov 28, 2022
The Globe and Mail
Mon Nov 28, 2022
Lexagene Holdings is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation...
Lexagene Holdings: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (LXG)
The Globe and Mail - Mon Oct 3, 2022
The Globe and Mail
Mon Oct 3, 2022
Lexagene Holdings is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation...
Lexagene Holdings: Top 10 Undervalued Medical Devices & Instruments Industry Sector Stocks on TSX Venture Exchange (LXG)
The Globe and Mail - Mon Sep 5, 2022
The Globe and Mail
Mon Sep 5, 2022
Lexagene Holdings is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to...
LexaGene Reduces Time-to-Result by ~35%
Globe Newswire - Wed Aug 10, 2022
Globe Newswire
Wed Aug 10, 2022
BEVERLY, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...
LexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees
Globe Newswire - Fri Jul 29, 2022
Globe Newswire
Fri Jul 29, 2022
BEVERLY, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...
LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections
Globe Newswire - Wed Jul 27, 2022
Globe Newswire
Wed Jul 27, 2022
BEVERLY, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...
LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections
Globe Newswire - Tue Jul 5, 2022
Globe Newswire
Tue Jul 5, 2022
BEVERLY, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...
LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin
Globe Newswire - Fri Jul 1, 2022
Globe Newswire
Fri Jul 1, 2022
BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...